AOU Policlinico G.Martino
Messina 98125
4 studies enrolling now · 16 studies all time
What they study most
Anti-myostatin, Atrophy, Bronchiectasis, Cervical Dystonia, Chemotherapy-induced Peripheral Neuropathy, Chronic Kidney Disease, Colitis, Ulcerative, Crohn Disease, Crohn's Disease, Diabetes Mellitus, Type 2, Hepatocellular Carcinoma, Hepatocellular Carcinoma Surveillance
Studies at this site
- The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis — Recruiting now
- PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease — Recruiting now
- Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD) — Recruiting now
- International CIPN Assessment and Validation Study — Recruiting now
- A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
- A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
- A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
- A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
- Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam — Completed
- EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) — Completed
- Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year — Completed
- Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease — Completed
- Phase IV-Cervical Dystonia-INTEREST IN CD2 — Completed
- Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma — Completed
- CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes — Completed
- Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) — Completed